Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Carlsmed, Inc. (CARL : NSDQ)
 
 • Company Description   
Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif.

Number of Employees: 100

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.35 Daily Weekly Monthly
20 Day Moving Average: 68,690 shares
Shares Outstanding: 26.59 (millions)
Market Capitalization: $328.42 (millions)
Beta:
52 Week High: $17.19
52 Week Low: $11.45
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -14.30% -14.15%
12 Week -9.66% -11.11%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1800 ASTON AVENUE SUITE 100
-
CARLSBAD,CA 92008
USA
ph: 858-295-9290
fax: -
None http://www.carlsmed.com
 
 • General Corporate Information   
Officers
Michael (Mike) Cordonnier - Chief Executive Officer; President; Chairman
Leonard (Leo) Greenstein - Chief Financial Officer; Treasurer
Niall Casey - Director
Philip (Phil) Young - Director
Kevin Sidow - Director

Peer Information
Carlsmed, Inc. (HLIS)
Carlsmed, Inc. (AZTA)
Carlsmed, Inc. (APYI)
Carlsmed, Inc. (RNVA)
Carlsmed, Inc. (HMSY)
Carlsmed, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 14280C105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 07/21/26
Share - Related Items
Shares Outstanding: 26.59
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $328.42 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.34 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.64 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 37.84% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/21/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.08
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 72.79%
Sales Growth
vs. Year Ago Period: 98.39%
vs. Previous Quarter: 8.20%
ROE
12/31/25 - -
09/30/25 - -
06/30/25 - -
ROA
12/31/25 - -
09/30/25 - -
06/30/25 - -
Current Ratio
12/31/25 - -
09/30/25 - 12.03
06/30/25 - -
Quick Ratio
12/31/25 - -
09/30/25 - 11.91
06/30/25 - -
Operating Margin
12/31/25 - -
09/30/25 - -
06/30/25 - -
Net Margin
12/31/25 - -
09/30/25 - -
06/30/25 - -
Pre-Tax Margin
12/31/25 - -
09/30/25 - -
06/30/25 - -
Book Value
12/31/25 - -
09/30/25 - 4.01
06/30/25 - -
Inventory Turnover
12/31/25 - -
09/30/25 - -
06/30/25 - -
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.14
06/30/25 - -
Debt-to-Capital
12/31/25 - -
09/30/25 - 12.65
06/30/25 - -
 

Powered by Zacks Investment Research ©